Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.

Wang Y, Zhang Z, Lubet RA, You M.

Oncogene. 2006 Feb 23;25(8):1277-80.

PMID:
16247444
2.

Molecular pathogenesis of transplacentally induced mouse lung tumors.

Miller MS, Leone-Kabler S, Rollins LA, Wessner LL, Fan M, Schaeffer DO, McEntee MF, O'Sullivan MG.

Exp Lung Res. 1998 Jul-Aug;24(4):557-77. Review.

PMID:
9659583
3.

Use of p53 transgenic mice in the development of cancer models for multiple purposes.

Lubet RA, Zhang Z, Wiseman RW, You M.

Exp Lung Res. 2000 Dec;26(8):581-93. Review.

PMID:
11195457
4.

Molecular comparison of human and mouse pulmonary adenocarcinomas.

Malkinson AM.

Exp Lung Res. 1998 Jul-Aug;24(4):541-55. Review.

PMID:
9659582
5.

Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.

Yoshidome K, Shibata MA, Maroulakou IG, Liu ML, Jorcyk CL, Gold LG, Welch VN, Green JE.

Int J Oncol. 1998 Feb;12(2):449-53. Review.

PMID:
9458374
6.

Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.

Herzog CR, Lubet RA, You M.

J Cell Biochem Suppl. 1997;28-29:49-63. Review.

PMID:
9589349
7.

Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma.

Malkinson AM.

Cancer Res. 1992 May 1;52(9 Suppl):2670s-2676s. Review.

8.

Diet and cancer prevention studies in p53-deficient mice.

Hursting SD, Perkins SN, Phang JM, Barrett JC.

J Nutr. 2001 Nov;131(11 Suppl):3092S-4S. Review.

9.

Modeling human lung cancer in mice: similarities and shortcomings.

Tuveson DA, Jacks T.

Oncogene. 1999 Sep 20;18(38):5318-24. Review.

10.

Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.

Solomon H, Brosh R, Buganim Y, Rotter V.

Discov Med. 2010 May;9(48):448-54. Review.

11.

The p53-deficient mouse: a model for basic and applied cancer studies.

Donehower LA.

Semin Cancer Biol. 1996 Oct;7(5):269-78. Review.

PMID:
9110404
12.

Mouse models dissect the role of p53 in cancer and development.

Lozano G, Liu G.

Semin Cancer Biol. 1998;8(5):337-44. Review.

PMID:
10101799
14.

Probing p53 biological functions through the use of genetically engineered mouse models.

Attardi LD, Donehower LA.

Mutat Res. 2005 Aug 25;576(1-2):4-21. Review.

PMID:
16038709
15.

The complexities of an apparently simple lung tumor model: The A/J mouse.

Witschi H.

Exp Toxicol Pathol. 2005 Jul;57 Suppl 1:171-81. Review.

PMID:
16092725
16.

Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis.

Maciag A, Anderson LM.

Exp Lung Res. 2005 Jan-Feb;31(1):83-104. Review.

PMID:
15765920
17.

Molecular footprints of human lung cancer progression.

Yokota J, Kohno T.

Cancer Sci. 2004 Mar;95(3):197-204. Review.

18.

The genetic basis of susceptibility to lung tumors in mice.

Malkinson AM.

Toxicology. 1989 Mar;54(3):241-71. Review. Erratum in: Toxicology 1989 May 15;55(3):349.

PMID:
2650016
19.

The development and progression of adenocarcinoma of the lung.

Noguchi M, Shimosato Y.

Cancer Treat Res. 1995;72:131-42. Review.

PMID:
7702984
20.

Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer.

Wakamatsu N, Devereux TR, Hong HH, Sills RC.

Toxicol Pathol. 2007 Jan;35(1):75-80. Review.

Supplemental Content

Support Center